Articles tagged "Outcome"

2022 American Transplant Congress
Hold the Opioids Please: Long-Term Outcomes Following an Opioid Minimization Protocol in Kidney Transplantation
T. Carcella, N. Patel, J. Marable, J. Fleming, P. Baliga, D. Dubay, S. Bethi, D. Taber, V. Rohan
Medical University of South Carolina, Charleston, SC
*Purpose: Opioid use following kidney transplantation (KTX) is associated with an increased risk of graft loss and mortality. Opioid minimization strategies and protocols have demonstrated…
2022 American Transplant Congress
Early Outcomes for Liver Transplant with Thoracoabdominal Normothermic Regional Perfusion for Donation After Circulatory Death: A Multi-Center Experience
A. L. Brubaker¹, A. Lee¹, B. Jackson¹, J. Berumen¹, J. R. Parekh¹, K. L. Mekeel¹, A. R. Gupta², J. M. Gardner², T. Chaly³, A. K. Mathur⁴, C. Jadlowiec⁴, K. Reddy⁴, R. Nunez⁴, J. Bellingham⁵, E. Thomas⁶, J. R. Wellen⁷, M. Kearns¹, V. Pretorius¹, G. T. Schnickel¹
¹UC San Diego, San Diego, CA, ²UC San Francisco, San Francisco, CA, ³Arizona Transplant Associates, Phoenix, AZ, ⁴Mayo Clinic Arizona, Phoenix, AZ, ⁵California Pacific Medical Center, Orinda, CA, ⁶University of Texas, San Antonio, TX, ⁷Washington University, Saint Louis, MO
*Purpose: We evaluated early outcomes of liver transplant after thoracoabdominal normothermic regional perfusion (TA-NRP) for controlled donation after circulatory death (cDCD) donors.*Methods: We identified liver…
2022 American Transplant Congress
A2/A2B to B Kidney Transplantation Outcomes: A Single-Center 5 Year Experience
A. El Chediak, S. Shawar, M. Fallahzadeh, I. Feurer, S. Rega, J. L. Triozzi, D. Shaffer
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The new kidney allocation system (KAS) instituted in 2014 allowed organ procurement organizations to allocate A2/A2B to B candidates preferentially was meant to improve…
2022 American Transplant Congress
Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence
J. Kwon
Surgery, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Several treatments have recently been known for hepatocellcular carcinoma (HCC) who have failed to treat sorafenib. Immune checkpoint inhibitors have proven to be effective,…
2022 American Transplant Congress
Does Dialysis Modality or Duration Influence Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients?
M. Garner¹, B. Sharda², A. Farney³, J. Rogers², G. Orlando³, C. Jay⁴, A. Reeves-Daniel⁵, A. Mena-Gutierrez³, N. Sakhovskaya³, R. Stratta⁶
¹Transplant Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ²Wake Forest Baptist Medical Center, Winston Salem, NC, ³Wake Forest Baptist Medical Center, Winston-Salem, NC, ⁴Wake Forest Baptist Health, Winston-Salem, NC, ⁵Wake Forest University, Winston Salem, NC, ⁶Wake Forest Univ, Winston-Salem, NC
*Purpose: The influence of dialysis modality and duration on outcomes following simultaneous pancreas-kidney transplantation (SPKT) remains uncertain. The study purpose was to review our single…
2022 American Transplant Congress
Computer vs Human-Based Prediction and Stratification of the Risk of Long-Term Kidney Allograft Failure
G. Divard¹, M. Raynaud¹, V. Tataputii², B. Abdalla³, C. Legendre¹, C. Lefaucheur¹, O. Aubert¹, A. Loupy¹
¹Paris Transplant Group, Paris, France, ²NYU Langone Health, New York, NY, ³UCLA, Los Angeles, CA
*Purpose: Clinical decision-making process after transplantation is mainly driven by patient individual risk of allograft failure prediction assessed by physicians. However, this task remains difficult…
2022 American Transplant Congress
Evaluation of Technical Bladder Complications in Kidney Transplantation Recipients with a Prolonged Dialysis History
S. M. Zielsdorf, K. Kushwaha, C. Goldbeck, S. Martin, Y. Kwon, K. Etesami, J. Kim, J. Emamaullee, S. Zielsdorf
University of Southern California, Los Angeles, CA
*Purpose: The kidney transplant (KT) waiting list continues to expand, resulting in prolonged dialysis times of >8 years prior to transplantation in some regions. The…
2022 American Transplant Congress
Impact of Sarcopenia Using L3 and Thigh Skeletal Muscle Index on Clinical Outcomes in Liver Transplantation Recipient
M. Lim, J. Kim
Department of Surgery, Samsung Medical Cener, Seoul, Korea, Republic of
*Purpose: Sarcopenia is defined as loss of muscle mass and function. It has been reported as a significant risk factor for outcome after Liver transplantation…
2022 American Transplant Congress
A Comparison of Vibration Controlled Transient Elastography, FAST, AGILE-3 and AGILE-4 Scores in Liver Transplant Recipients
T. Arshad¹, M. Tseng², B. Anh³, T. Syed⁴, A. Miller⁵, V. Patel⁴, A. Asgharpour⁴, I. O. Michael⁶, S. Patel⁵, M. Muthiah⁷, M. S. Siddiqui⁴
¹Department of Internal Medicine, VCU, Richmond, VA, ²Internal Medicine, VCU, Richmond, VA, ³Department of Statistical Sciences & Operations Research, VCU, Richmond, VA, ⁴Division of Gastroenterology and Hepatology, VCU, Richmond, VA, ⁵VCU, Richmond, VA, ⁶Department of Pathology, VCU, Richmond, VA, ⁷National University of Singapore, Singapore, Singapore
*Purpose: Hepatic fibrosis is a strong predictor of clinical outcomes following liver transplantation (LT), however, non-invasive fibrosis assessment remains challenging. Vibration controlled transient elastography has…
2022 American Transplant Congress
Liver Transplant Recipient History of Criminality: Impact on Clinical Outcomes
M. M. French¹, R. Mangus¹, R. Holmes¹, A. Krause¹, J. Sumner¹, C. Kubal¹, B. Ekser², P. Mihaylov³, A. Lutz⁴, J. Fridell⁵
¹Department of Surgery, Indiana University, Indianapolis, IN, ²Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, ³Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, ⁴Department of Surgery, Indiana University, Fishers, IN, ⁵Department of Surgery, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Health disparities are present in transplantation, just as in other areas of medicine. This is a retrospective review of liver transplant (LT) recipients to…